BrainStorm Cell Therapeutics to Present New Biomarker Data S

The data will be presented at the Annual ALS Drug Development Summit, which is focused on identifying transformative ALS targets, seeking translational biomarkers and propelling more clinical...

Related Keywords

Boston , Massachusetts , United States , California , Clene Nanomedicine , Antonio Trejo , Marjan Sepassi , Angela Genge , Mary Kay Turner , Stacy Lindborg , Michael Wood , Christopher Ocampo , Lisa Guiterman , National Ms Society , Access Program , Nurown Program , Global Patient Advocacy Public Affairs , European Medicines Agency , California Institute For Regenerative Medicine , Brainstorm Cell Therapeutics Inc , Nasdaq , Mcgill University , Nurown Expanded Access Program , Drug Administration , Regulatory Affairs At Brainstorm , Drug Development Summit , Centre Of Excellence , Prnewswire Brainstorm Cell Therapeutics Inc , Development Summit , Storm Cell Therapeutics , Lindborg Phd , Promising Longer Term Biomarker Data , Hyatt Regency , Expanded Access Program , Regulatory Affairs , Surrogate Landscape , People Living , Senior Medical Director , Vice President , Medical Affairs , Kay Turner , Senior Vice President , Global Patient Advocacy , Public Affairs , Kylan Morris Senior Manager , Patient Advocacy , Leveraging Insight , Real Life Experiences , How Do People Living , Which Trial They Want , Floor Effect , Orphan Drug , California Institute , Regenerative Medicine , Regarding Forward Looking Statements , Special Protocol Assessment ,